Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales
- PMID: 29793546
- PMCID: PMC5968621
- DOI: 10.1186/s13195-018-0376-9
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales
Abstract
Background: In patients with frontotemporal dementia, it has been shown that brain atrophy occurs earliest in the anterior cingulate, insula and frontal lobes. We used visual rating scales to investigate whether identifying atrophy in these areas may be helpful in distinguishing symptomatic patients carrying different causal mutations in the microtubule-associated protein tau (MAPT), progranulin (GRN) and chromosome 9 open reading frame (C9ORF72) genes. We also analysed asymptomatic carriers to see whether it was possible to visually identify brain atrophy before the appearance of symptoms.
Methods: Magnetic resonance imaging of 343 subjects (63 symptomatic mutation carriers, 132 presymptomatic mutation carriers and 148 control subjects) from the Genetic Frontotemporal Dementia Initiative study were analysed by two trained raters using a protocol of six visual rating scales that identified atrophy in key regions of the brain (orbitofrontal, anterior cingulate, frontoinsula, anterior and medial temporal lobes and posterior cortical areas).
Results: Intra- and interrater agreement were greater than 0.73 for all the scales. Voxel-based morphometric analysis demonstrated a strong correlation between the visual rating scale scores and grey matter atrophy in the same region for each of the scales. Typical patterns of atrophy were identified: symmetric anterior and medial temporal lobe involvement for MAPT, asymmetric frontal and parietal loss for GRN, and a more widespread pattern for C9ORF72. Presymptomatic MAPT carriers showed greater atrophy in the medial temporal region than control subjects, but the visual rating scales could not identify presymptomatic atrophy in GRN or C9ORF72 carriers.
Conclusions: These simple-to-use and reproducible scales may be useful tools in the clinical setting for the discrimination of different mutations of frontotemporal dementia, and they may even help to identify atrophy prior to onset in those with MAPT mutations.
Keywords: Frontotemporal dementia; Genetics; MRI; Visual rating.
Conflict of interest statement
Ethics approval and consent to participate
Local ethics committees approved the study at each site, and all participants provided written informed consent.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.J Alzheimers Dis. 2018;65(1):147-163. doi: 10.3233/JAD-180053. J Alzheimers Dis. 2018. PMID: 30010122 Free PMC article.
-
Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.Brain. 2012 Mar;135(Pt 3):794-806. doi: 10.1093/brain/aws001. Brain. 2012. PMID: 22366795 Free PMC article.
-
Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.JAMA Netw Open. 2020 Oct 1;3(10):e2022847. doi: 10.1001/jamanetworkopen.2020.22847. JAMA Netw Open. 2020. PMID: 33112398 Free PMC article.
-
Phenotypic signatures of genetic frontotemporal dementia.Curr Opin Neurol. 2011 Dec;24(6):542-9. doi: 10.1097/WCO.0b013e32834cd442. Curr Opin Neurol. 2011. PMID: 21986680 Review.
-
An update on genetic frontotemporal dementia.J Neurol. 2019 Aug;266(8):2075-2086. doi: 10.1007/s00415-019-09363-4. Epub 2019 May 22. J Neurol. 2019. PMID: 31119452 Free PMC article. Review.
Cited by
-
Six Visual Rating Scales as A Biomarker for Monitoring Atrophied Brain Volume in Parkinson's Disease.Aging Dis. 2020 Oct 1;11(5):1082-1090. doi: 10.14336/AD.2019.1103. eCollection 2020 Oct. Aging Dis. 2020. PMID: 33014524 Free PMC article.
-
Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.Neuroradiol J. 2021 Aug;34(4):263-288. doi: 10.1177/1971400921998968. Epub 2021 Mar 5. Neuroradiol J. 2021. PMID: 33666110 Free PMC article. Review.
-
Normal cohorts in automated brain atrophy estimation: how many healthy subjects to include?Eur Radiol. 2024 Aug;34(8):5276-5286. doi: 10.1007/s00330-023-10522-5. Epub 2024 Jan 8. Eur Radiol. 2024. PMID: 38189981 Free PMC article.
-
The role of magnetic resonance imaging in the diagnosis and prognosis of dementia.Biomol Biomed. 2023 Mar 16;23(2):209-224. doi: 10.17305/bjbms.2022.8085. Biomol Biomed. 2023. PMID: 36453893 Free PMC article. Review.
-
Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar Degeneration.Front Neurol. 2020 Feb 28;11:80. doi: 10.3389/fneur.2020.00080. eCollection 2020. Front Neurol. 2020. PMID: 32184751 Free PMC article. Review.
References
-
- Rohrer JD, Nicholas JM, Cash DM, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253–262. doi: 10.1016/S1474-4422(14)70324-2. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous